Delivering Curative Therapies: Autologous vs. Allogeneic Supply Chains

About the Author

Director, CMC Commercial Strategy

Immatics

Dr. Pinar Cicalese is the Director of CMC Commercial Strategy at Immatics for adoptive cell therapies targeting various solid cancers. Pinar has nearly 20 years...

Niranjan S. Kulkarni, PhD

Senior Director, Consulting Services

CRB

Niranjan S. Kulkarni, PhD, Senior Director, Consulting Services with CRB Consulting Engineers, Inc. holds Ph.D. in Industrial and Systems Engineering from Binghamton University and is...

Features

Digital Display Labeling in Clinical Supplies for Clinical Trials

1 March 2024

Digital display labels (DDLs) offer an alternative solution to eliminate manual relabeling in the clinical supply chain, optimizing label content updates through a simple, system-controlled approach while providing new, uncharted opportunities. With increased efficiency in making regulatory-compliant changes and enhanced flexibility in the clinical supply chain, DDL technology has the...

Features

Evolving China’s Regulatory System in Alignment with ICH

1 March 2024

With the Chinese government initiating drug regulatory reform in 2015 and China joining the International Council for Harmonisation (ICH) in 2017, a significant number of measures have been implemented by the government. The aim is to make fundamental changes to China’s drug regulatory administration system so it can facilitate pharmaceutical development and better meet patient needs in the...

Features

Navigating the Asia Pacific Pharmaceutical Landscape for Global Impact

1 March 2024

The Asia Pacific region (APAC), like any large territory, encompasses a blend of well-established and early-stage economies, diverse healthcare systems, and differences in language, culture, politics, and technology adoption. APAC’s size and complexity has created new challenges and opportunities for the pharmaceutical industry as nations work together to meet the manufacturing needs for...

About the Author

Facilities of the Future: Meeting the Demands of Breakthrough Therapeutics

Emerging Leader Hacker to GAMPer in 10 Weeks

New Initiative Seeks to Back up ICHs Harmonization Mission

Data Science-Assisted Biopharmaceutical Tech Transfer and Process Characterization

Entering a New Era of Innovation and Collaboration With the Focus on the Workforce of the Future

Q&A with ISPE Foundation Professional Development Grant Recipient Silas Tamufor

Related Articles